| Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced Non … BH Grønberg, RM Bremnes, Ø Fløtten, T Amundsen, PF Brunsvig, ... Journal of clinical oncology 27 (19), 3217-3224, 2009 | 405 | 2009 |
| Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer C Von Plessen, B Bergman, O Andresen, RM Bremnes, S Sundstrøm, ... British journal of cancer 95 (8), 966-973, 2006 | 213 | 2006 |
| Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy BH Grønberg, S Sundstrøm, S Kaasa, RM Bremnes, Ø Fløtten, ... European journal of cancer 46 (12), 2225-2234, 2010 | 141 | 2010 |
| Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data A Rossi, P Chiodini, JM Sun, MER O'Brien, C von Plessen, F Barata, ... The Lancet Oncology 15 (11), 1254-1262, 2014 | 139 | 2014 |
| Sustainability of healthcare improvement: what can we learn from learning theory? E Hovlid, O Bukve, K Haug, AB Aslaksen, C von Plessen BMC health services research 12, 1-13, 2012 | 131 | 2012 |
| A new pathway for elective surgery to reduce cancellation rates E Hovlid, O Bukve, K Haug, AB Aslaksen, C von Plessen BMC health services research 12, 1-9, 2012 | 110 | 2012 |
| Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity N Helbekkmo, SH Sundstrøm, U Aasebø, P Fr Brunsvig, C Von Plessen, ... British journal of cancer 97 (3), 283-289, 2007 | 100 | 2007 |
| Talking about quality: exploring how ‘quality’is conceptualized in European hospitals and healthcare systems S Wiig, K Aase, C Von Plessen, S Burnett, F Nunes, AM Weggelaar, ... BMC health services research 14, 1-12, 2014 | 96 | 2014 |
| Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community C Von Plessen, Ø Grinde, A Gulsvik Respiratory medicine 97 (4), 428-435, 2003 | 83 | 2003 |
| Experiences with global trigger tool reviews in five Danish hospitals: an implementation study C von Plessen, AM Kodal, J Anhøj BMJ open 2 (5), e001324, 2012 | 62 | 2012 |
| Patient experiences with interventions to reduce surgery cancellations: a qualitative study E Hovlid, C von Plessen, K Haug, AB Aslaksen, O Bukve BMC surgery 13, 1-7, 2013 | 57 | 2013 |
| Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study GB Egelund, AV Jensen, SB Andersen, PT Petersen, BØ Lindhardt, ... BMC pulmonary medicine 17, 1-9, 2017 | 49 | 2017 |
| Rate and predictors for non-attendance of patients undergoing hospital outpatient treatment for chronic diseases: a register-based cohort study DL Wolff, FB Waldorff, C von Plessen, CB Mogensen, TL Sørensen, ... BMC health services research 19, 1-11, 2019 | 48 | 2019 |
| Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysis CH Saunders, A Sierpe, C von Plessen, AM Kennedy, LC Leviton, ... bmj 381, 2023 | 42 | 2023 |
| Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study … Ø Fløtten, BH Grønberg, R Bremnes, T Amundsen, S Sundstrøm, H Rolke, ... British journal of cancer 107 (3), 442-447, 2012 | 42 | 2012 |
| Hospital accreditation: staff experiences and perceptions SB Bogh, A Blom, DC Raben, J Braithwaite, B Thude, E Hollnagel, ... International journal of health care quality assurance 31 (5), 420-427, 2018 | 39 | 2018 |
| Improving the quality of palliative care for ambulatory patients with lung cancer C von Plessen, A Aslaksen Bmj 330 (7503), 1309-1313, 2005 | 38 | 2005 |
| Adverse events in hospitalised cancer patients: a comparison to a general hospital population EC Haukland, C von Plessen, C Nieder, B Vonen Acta oncologica 56 (9), 1218-1223, 2017 | 36 | 2017 |
| A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer BH Grønberg, RM Bremnes, U Aasebø, P Brunsvig, Ø Fløtten, ... Lung cancer 63 (1), 88-93, 2009 | 34 | 2009 |
| Contribution of adverse events to death of hospitalised patients EC Haukland, K Mevik, C von Plessen, C Nieder, B Vonen BMJ open quality 8 (1), e000377, 2019 | 31 | 2019 |
Bjørn Henning GrønbergProfessor of Oncology在 ntnu.no 的电子邮件经过验证
